Compare LUV & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUV | MEDP |
|---|---|---|
| Founded | 1967 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5B | 17.2B |
| IPO Year | 1995 | 2016 |
| Metric | LUV | MEDP |
|---|---|---|
| Price | $46.32 | $666.11 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 26 | 14 |
| Target Price | $50.01 | ★ $651.31 |
| AVG Volume (30 Days) | ★ 6.1M | 302.0K |
| Earning Date | 10-21-2026 | 10-21-2026 |
| Dividend Yield | ★ 1.55% | N/A |
| EPS Growth | 3.95 | ★ 20.98 |
| EPS | 1.47 | ★ 13.37 |
| Revenue | N/A | N/A |
| Revenue This Year | $19.64 | $12.62 |
| Revenue Next Year | $6.88 | $6.03 |
| P/E Ratio | ★ $31.35 | $50.41 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $31.15 | $373.00 |
| 52 Week High | $55.11 | $693.97 |
| Indicator | LUV | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 62.62 | 56.19 |
| Support Level | $37.33 | $575.64 |
| Resistance Level | $49.93 | $685.94 |
| Average True Range (ATR) | 1.65 | 22.49 |
| MACD | 0.40 | -1.24 |
| Stochastic Oscillator | 89.65 | 54.37 |
Southwest Airlines is the largest domestic air carrier in the United States by passengers boarded. Southwest operates nearly 800 aircraft in an all-Boeing 737 fleet. Despite offering some longer routes and a few perks for business travelers, the airline predominantly specializes in short-haul, leisure flights operated with a simple cabin configuration in a point-to-point network. In early 2026, Southwest modified its cabins to offer some rows with extra legroom, its ticketing process and merchandising to offer assigned seats, and more fare categories to include a basic economy class that appears for the first time in travel aggregators' search results and more directly competes with other airlines' offerings.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.